FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DE VAERE ROBERT J

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/2/2007 

3. Issuer Name and Ticker or Trading Symbol

IDM PHARMA, INC. [IDMI]

(Last)        (First)        (Middle)

C/O IDM PHARMA, INC, 9 PARKER, SUITE 100

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Sr. VP and CFO /

(Street)

IRVINE, CA 92618       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

5/4/2007 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   10401   (1) I   (2) Held in a brokerage account.  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  A Form 3 filed on May 4, 2007 erroneously indicated that the reporting person directly owned 20,401 shares of common stock, when in fact 10,000 of these shares were disposed of by the reporting person in April 2007. As of May 2, 2007, the reporting person beneficially owned only 10,401 shares of common stock.
( 2)  Reporting person has voting and investment control over the shares.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DE VAERE ROBERT J
C/O IDM PHARMA, INC
9 PARKER, SUITE 100
IRVINE, CA 92618

Sr. VP and CFO

Signatures
Jackie Fritz, Asst. Secretary by Power of Attorney 5/13/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Idm Pharma (NASDAQ:IDMI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Idm Pharma Charts.
Idm Pharma (NASDAQ:IDMI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Idm Pharma Charts.